Primary Prevention Youth Suicide Trial in Colorado High Schools Prevention Among Colorado High School Students

NCT03014271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-03-13

No results posted yet for this study

Summary

Sources of Strength is an evidence based program for youth suicide that trains student key leaders to strengthen social connectedness and healthy norms school-wide and is listed on the National Registry of Evidence Based Programs and Practices (NREPP). This project will expand the existing evidence base by evaluating Sources of Strength for sexual violence outcomes in a randomized controlled trial (RCT) in twenty-four high schools.

Conditions

  • Suicide
  • Sexual Violence

Interventions

BEHAVIORAL

Sources of Strength (SOS) Prevention Program

Sources of Strength is an evidence based program for youth suicide that trains student key leaders to strengthen social connectedness and healthy norms school-wide and is listed on the National Registry of Evidence Based Programs and Practices (NREPP).

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER
  • Texas Tech University

    collaborator OTHER
  • Colorado Department of Public Health and Environment

    collaborator OTHER_GOV
  • Centers for Disease Control and Prevention

    collaborator FED
  • University of Florida

    lead OTHER

Principal Investigators

  • Tomei Kuehl, MPA · Colorado Department of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-21
Primary Completion
2019-09-11
Completion
2019-09-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014271 on ClinicalTrials.gov